These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14671867)

  • 1. Pharma focus. Puff adders.
    Chapman S
    Health Serv J; 2003 Nov; 113(5883):suppl 6-7. PubMed ID: 14671867
    [No Abstract]   [Full Text] [Related]  

  • 2. Pressure point. When coughing up is essential.
    Cooper C
    Health Serv J; 2000 Nov; 110(5733):suppl 1. PubMed ID: 11138527
    [No Abstract]   [Full Text] [Related]  

  • 3. Budget busters.
    Cresswell J
    Community Nurse; 1999 Oct; 5(9):10. PubMed ID: 10732567
    [No Abstract]   [Full Text] [Related]  

  • 4. Leucotriene receptor antagonists for asthma can save millions, says NICE.
    Wise J
    BMJ; 2016 Dec; 355():i6835. PubMed ID: 28031161
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.
    O'Neill S; Sweeney J; Patterson CC; Menzies-Gow A; Niven R; Mansur AH; Bucknall C; Chaudhuri R; Thomson NC; Brightling CE; O'Neill C; Heaney LG;
    Thorax; 2015 Apr; 70(4):376-8. PubMed ID: 24917087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care.
    Arnlind MH; Nokela M; Rehnberg C; Jonsson EW
    J Asthma; 2006 Oct; 43(8):585-91. PubMed ID: 17050222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicines management. Fit to bust.
    Calvert R
    Health Serv J; 2002 Oct; 112(5826):24-5. PubMed ID: 12397667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic realities and the health plight of Americans.
    Wolf BL
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):170-1. PubMed ID: 26231466
    [No Abstract]   [Full Text] [Related]  

  • 9. Asthma medication.
    Rogol PR
    Conn Med; 2008 Aug; 72(7):441. PubMed ID: 18763675
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary: Bevan's covenant continues intact.
    Hurwitz B
    BMJ; 1998 Nov; 317(7169):1365. PubMed ID: 9882107
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescribing budgets. Group therapy.
    Davies J
    Health Serv J; 1999 Mar; 109(5644):suppl 1-4. PubMed ID: 10387213
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacotherapeutical management of bronchial asthma].
    Leont'ev SL; Mikhaĭlov VG; Nevzorova VP; Sadovnikova RV; Shabashov AF; Lugovkina TK; Leshchenko IV; Bel'tiukov EK; Lebedeva MK
    Klin Med (Mosk); 1998; 76(10):39-41. PubMed ID: 9865016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacoeconomic aspects of bronchial asthma].
    Prosekova EV; Gel'tser BI; Shestovskaia TN
    Ter Arkh; 2000; 72(3):55-8. PubMed ID: 10776656
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Biological Agents in Asthma: Pharmacoeconomic Lessons Learned From Omalizumab.
    Draikiwicz S; Oppenheimer J
    Chest; 2017 Feb; 151(2):249-251. PubMed ID: 28183482
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacoeconomics of asthma].
    Jahnz-Rózyk K; Targowski T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():48-9. PubMed ID: 15524016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma treatment: improving efficacy. Reducing costs.
    Muñoz-López F
    Allergol Immunopathol (Madr); 2001; 29(6):223-8. PubMed ID: 11834180
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analyzing the economy, something is changing concerning asthma].
    Serra Batlles J
    Arch Bronconeumol; 2009 Oct; 45(10):475-7. PubMed ID: 19758739
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of asthma controller medications on medical and economic resource utilization in adult asthma patients.
    Lee TA; Chang CL; Stephenson JJ; Sajjan SG; Maiese EM; Everett S; Allen-Ramey F
    Curr Med Res Opin; 2010 Dec; 26(12):2851-60. PubMed ID: 21070096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the cost-effectiveness of omalizumab.
    Campbell JD; Spackman DE; Sullivan SD
    Allergy; 2007 Dec; 62(12):1469. PubMed ID: 17983382
    [No Abstract]   [Full Text] [Related]  

  • 20. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis.
    Thomas M; Kocevar VS; Zhang Q; Yin DD; Price D
    Pediatrics; 2005 Jan; 115(1):129-34. PubMed ID: 15629992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.